Atopic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria of atopic dermatitis; 2. Patients who meet the syndrome differentiation standard of heart fire and spleen deficiency; 3. Patients aged 6-12 years (= 8 years old) should sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Contact dermatitis, chronic simple lichen, psoriasis, ichthyosis, enteropathic acrodermatitis, neonatal acne, peritrichokeratosis, scabies, etc; 2. Patients with acute lesions accompanied by erosion, exudation or severe skin infection, or local skin lesions with severe bacterial, fungal or viral infection; 3. Children with acute asthma or those who need systemic hormone maintenance therapy; 4. Children who had been treated with glucocorticoid, immunosuppressive agents and ultraviolet rays within 4 weeks before enrollment, antihistamines within 2 weeks before enrollment and topical drugs (such as TCS and TCI) within 1 week before enrollment; 5. Patients with other serious systemic diseases such as cardiovascular, brain, liver, kidney and hematopoietic system; 6. Patients who are allergic to known ingredients of the test drug; 7. Patients who are considered unsuitable by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCORAD score; | — |
Secondary
| Measure | Time frame |
|---|---|
| IGA score;Skin lesion recurrence;TCM syndrome score;CDLQI score; | — |
Countries
China
Contacts
Yuekang Pharmaceutical Group Co., Ltd